CNBC’s Melissa Lee and Jared Holz, Mizuho Americas healthcare sector strategist, join ‘Squawk on Street’ to discuss the weight-loss drug market, why he believes Eli Lilly and Novo Nordisk will remain the frontrunners for the next 2-3 years, and more.
Eli Lilly and Novo Nordisk will remain leaders in the weight-loss drug market: Mizuho’s Jared Holz
February 29, 2024
